636 related articles for article (PubMed ID: 37700339)
1. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics.
Jin HR; Wang J; Wang ZJ; Xi MJ; Xia BH; Deng K; Yang JL
J Hematol Oncol; 2023 Sep; 16(1):103. PubMed ID: 37700339
[TBL] [Abstract][Full Text] [Related]
2. The role of lipid metabolic reprogramming in tumor microenvironment.
Yang K; Wang X; Song C; He Z; Wang R; Xu Y; Jiang G; Wan Y; Mei J; Mao W
Theranostics; 2023; 13(6):1774-1808. PubMed ID: 37064872
[TBL] [Abstract][Full Text] [Related]
3. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
Zhu Y; Li X; Wang L; Hong X; Yang J
Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
[TBL] [Abstract][Full Text] [Related]
4. Contradictory roles of lipid metabolism in immune response within the tumor microenvironment.
Yu W; Lei Q; Yang L; Qin G; Liu S; Wang D; Ping Y; Zhang Y
J Hematol Oncol; 2021 Nov; 14(1):187. PubMed ID: 34742349
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages.
Wang Y; Wang D; Yang L; Zhang Y
Chin Med J (Engl); 2022 Oct; 135(20):2405-2416. PubMed ID: 36385099
[TBL] [Abstract][Full Text] [Related]
6. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming.
Li Z; Sun C; Qin Z
Theranostics; 2021; 11(17):8322-8336. PubMed ID: 34373744
[TBL] [Abstract][Full Text] [Related]
7. Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy.
Zhang M; Wei T; Zhang X; Guo D
Front Immunol; 2022; 13():937406. PubMed ID: 36131916
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral lipid metabolic reprogramming as a pro-tumoral regulator in the tumor milieu.
Wang R; Hu Q; Wu Y; Guan N; Han X; Guan X
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188962. PubMed ID: 37541532
[TBL] [Abstract][Full Text] [Related]
9. [Lipid Metabolic Reprogramming and Metabolic Stress in Liver Cancer].
Xu Z; Yuan KF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):561-565. PubMed ID: 34323031
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy.
Wu Y; Pu X; Wang X; Xu M
Lipids Health Dis; 2024 Feb; 23(1):35. PubMed ID: 38302980
[TBL] [Abstract][Full Text] [Related]
11. Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer.
Guo D; Ye L; Wu W; Yu X; Jin K
Acta Biochim Biophys Sin (Shanghai); 2023 Apr; 55(6):923-937. PubMed ID: 37021976
[TBL] [Abstract][Full Text] [Related]
12. Lipids in the tumor microenvironment: From cancer progression to treatment.
Corn KC; Windham MA; Rafat M
Prog Lipid Res; 2020 Nov; 80():101055. PubMed ID: 32791170
[TBL] [Abstract][Full Text] [Related]
13. Role of Aberrant Lipid Metabolism of Cancer Stem Cells in Cancer Progression.
Zhou J; Zhao J; Su C
Curr Cancer Drug Targets; 2021; 21(8):631-639. PubMed ID: 33726650
[TBL] [Abstract][Full Text] [Related]
14. Dietary fat and lipid metabolism in the tumor microenvironment.
Goswami S; Zhang Q; Celik CE; Reich EM; Yilmaz ÖH
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188984. PubMed ID: 37722512
[TBL] [Abstract][Full Text] [Related]
15. Lipid metabolism in cancer: New perspectives and emerging mechanisms.
Broadfield LA; Pane AA; Talebi A; Swinnen JV; Fendt SM
Dev Cell; 2021 May; 56(10):1363-1393. PubMed ID: 33945792
[TBL] [Abstract][Full Text] [Related]
16. Effect of metabolic reprogramming on the immune microenvironment in gastric cancer.
Shang Z; Ma Z; Wu E; Chen X; Tuo B; Li T; Liu X
Biomed Pharmacother; 2024 Jan; 170():116030. PubMed ID: 38128177
[TBL] [Abstract][Full Text] [Related]
17. Emerging data supporting stromal cell therapeutic potential in cancer: reprogramming stromal cells of the tumor microenvironment for anti-cancer effects.
Nwabo Kamdje AH; Seke Etet PF; Tagne Simo R; Vecchio L; Lukong KE; Krampera M
Cancer Biol Med; 2020 Nov; 17(4):828-841. PubMed ID: 33299638
[TBL] [Abstract][Full Text] [Related]
18. Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment.
Seo J; Yun JE; Kim SJ; Chun YS
Pflugers Arch; 2022 Jun; 474(6):591-601. PubMed ID: 35348849
[TBL] [Abstract][Full Text] [Related]
19. New dawn for cancer cell death: Emerging role of lipid metabolism.
Zhang C; Zhu N; Li H; Gong Y; Gu J; Shi Y; Liao D; Wang W; Dai A; Qin L
Mol Metab; 2022 Sep; 63():101529. PubMed ID: 35714911
[TBL] [Abstract][Full Text] [Related]
20. PPARα at the crossroad of metabolic-immune regulation in cancer.
Zeng W; Yin X; Jiang Y; Jin L; Liang W
FEBS J; 2022 Dec; 289(24):7726-7739. PubMed ID: 34480827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
